End-of-day quote
Shenzhen S.E.
18:00:00 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
11.8
CNY
|
+1.29%
|
|
-4.30%
|
-21.39%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,492
|
19,390
|
15,577
|
9,652
|
8,634
|
6,788
|
-
|
-
|
Enterprise Value (EV)
1 |
10,492
|
19,390
|
15,577
|
9,652
|
8,634
|
6,788
|
6,788
|
6,788
|
P/E ratio
|
48.1
x
|
83.3
x
|
82.1
x
|
52.4
x
|
42.9
x
|
22.7
x
|
16.3
x
|
15.4
x
|
Yield
|
-
|
-
|
0.55%
|
0.89%
|
1%
|
1.86%
|
3.14%
|
-
|
Capitalization / Revenue
|
6.61
x
|
10.5
x
|
6.93
x
|
3.71
x
|
2.99
x
|
2.08
x
|
1.7
x
|
1.63
x
|
EV / Revenue
|
6.61
x
|
10.5
x
|
6.93
x
|
3.71
x
|
2.99
x
|
2.08
x
|
1.7
x
|
1.63
x
|
EV / EBITDA
|
31.6
x
|
39.6
x
|
-
|
14.6
x
|
13.2
x
|
10.2
x
|
8.22
x
|
6.98
x
|
EV / FCF
|
-
|
-
|
357
x
|
-174
x
|
160
x
|
-73
x
|
158
x
|
-
|
FCF Yield
|
-
|
-
|
0.28%
|
-0.57%
|
0.62%
|
-1.37%
|
0.63%
|
-
|
Price to Book
|
6.87
x
|
11.3
x
|
4.57
x
|
2.76
x
|
2.4
x
|
1.78
x
|
1.62
x
|
1.55
x
|
Nbr of stocks (in thousands)
|
529,072
|
529,072
|
575,226
|
575,226
|
575,226
|
575,226
|
-
|
-
|
Reference price
2 |
19.83
|
36.65
|
27.08
|
16.78
|
15.01
|
11.80
|
11.80
|
11.80
|
Announcement Date
|
20-02-26
|
21-03-30
|
22-03-30
|
23-03-30
|
24-03-28
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,588
|
1,840
|
2,247
|
2,604
|
2,889
|
3,262
|
3,983
|
4,160
|
EBITDA
1 |
332.3
|
490.1
|
-
|
658.9
|
653.2
|
663.9
|
825.8
|
972.5
|
EBIT
1 |
173.8
|
232.1
|
201
|
181.2
|
199.9
|
307.5
|
429.6
|
452.4
|
Operating Margin
|
10.94%
|
12.61%
|
8.95%
|
6.96%
|
6.92%
|
9.43%
|
10.79%
|
10.88%
|
Earnings before Tax (EBT)
1 |
176.4
|
246.1
|
204.5
|
184.1
|
207.7
|
313.9
|
434.8
|
458.8
|
Net income
1 |
169.4
|
235.4
|
182.2
|
184
|
199.4
|
299.8
|
416.7
|
439.5
|
Net margin
|
10.67%
|
12.79%
|
8.11%
|
7.06%
|
6.9%
|
9.19%
|
10.46%
|
10.56%
|
EPS
2 |
0.4125
|
0.4400
|
0.3300
|
0.3200
|
0.3500
|
0.5200
|
0.7233
|
0.7650
|
Free Cash Flow
1 |
-
|
-
|
43.65
|
-55.47
|
53.87
|
-93
|
43
|
-
|
FCF margin
|
-
|
-
|
1.94%
|
-2.13%
|
1.86%
|
-2.85%
|
1.08%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
8.25%
|
-
|
5.21%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
23.96%
|
-
|
27.02%
|
-
|
10.32%
|
-
|
Dividend per Share
2 |
-
|
-
|
0.1500
|
0.1500
|
0.1500
|
0.2200
|
0.3700
|
-
|
Announcement Date
|
20-02-26
|
21-03-30
|
22-03-30
|
23-03-30
|
24-03-28
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-79.48
|
Net margin
|
-
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
22-04-27
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
43.7
|
-55.5
|
53.9
|
-93
|
43
|
-
|
ROE (net income / shareholders' equity)
|
18.4%
|
14.6%
|
6.81%
|
5.34%
|
5.65%
|
7.91%
|
9.79%
|
10.1%
|
ROA (Net income/ Total Assets)
|
-
|
7.53%
|
4.22%
|
-
|
3.28%
|
4.71%
|
5.32%
|
5.65%
|
Assets
1 |
-
|
3,126
|
4,313
|
-
|
6,071
|
6,365
|
7,833
|
7,778
|
Book Value Per Share
2 |
2.890
|
3.240
|
5.930
|
6.070
|
6.250
|
6.620
|
7.300
|
7.620
|
Cash Flow per Share
2 |
0.3200
|
0.7900
|
0.9000
|
0.9500
|
1.130
|
1.230
|
1.300
|
1.500
|
Capex
1 |
422
|
363
|
455
|
604
|
594
|
389
|
534
|
413
|
Capex / Sales
|
26.57%
|
19.71%
|
20.25%
|
23.2%
|
20.55%
|
11.94%
|
13.4%
|
9.94%
|
Announcement Date
|
20-02-26
|
21-03-30
|
22-03-30
|
23-03-30
|
24-03-28
|
-
|
-
|
-
|
Last Close Price
11.8
CNY Average target price
18.22
CNY Spread / Average Target +54.41% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.39% | 934M | | 0.00% | 8.44B | | -29.15% | 2.32B | | -23.44% | 2.33B | | -25.96% | 1.87B | | -16.13% | 958M | | +14.89% | 952M | | -7.47% | 699M | | -30.48% | 646M | | +4.91% | 572M |
Testing Laboratories
|